Robert J. Sheroff
President
Global Pharmaceutical Supply Group (GPSG)
Robert J. Sheroff resumed his career at Johnson & Johnson in June 2000 as Vice President of Worldwide Operations for Centocor. He went on to be President of the biologics manufacturing business, GBSC, in 2002, and was then appointed to his current position in August 2008, as President of the Global Pharmaceutical Supply Group (GPSG). Bob is responsible for overall strategy and leadership for manufacturing, distribution, quality & compliance, logistics and Global Technical Operations for an integrated supply chain that provides both large and small molecule technologies.
Previously, Mr. Sheroff gained a wide range of experience in quality and manufacturing. For seven years, he was Vice President of Worldwide Quality Operations for Warner Lambert, where he led quality for both the pharmaceutical and consumer sectors. Previously, he worked for 13 years for Johnson & Johnson's Ortho McNeil Pharmaceutical and Ortho Biotech units, holding biological and chemical manufacturing positions in the U.S., England and Puerto Rico. Mr. Sheroff holds a BS degree in Pharmacy from Rutgers University College of Pharmacy and an MBA in Pharmaceutical Marketing from Fairleigh Dickinson University.
Michael E. Kamarck, Ph.D.
President Merck BioVentures
SVP, Vaccines and Biologics Manufacturing
Michael E. Kamarck, Ph.D. joined Merck in 2009 as President of Merck BioVentures and SVP of Vaccines and Biologics Manufacturing. Dr. Kamarck's responsibilities cut across the human health, manufacturing and research divisions. He is responsible to establish a strong focus point for the ongoing development of this new Merck business Segment.
Dr. Kamarck has held positions of increasing responsibility for Wyeth from 2001-2009 and in 2008 was promoted President, Technical Operations & Product Supply (TO&PS). In that role he was responsible for all aspects of technical operations, late-stage process development and product supply for Wyeth, including Pharmaceuticals, BioPharma, Vaccines, Consumer Healthcare and Nutritionals. He was a member of the Wyeth Management Committee, Law/Regulatory Review Committee and Operations Committee. He began his career in biotechnology and pharmaceutical research for Bayer AG. Dr. Kamarck was the first US employee of two Bayer-owned biotechnology companies, and from 1982 to 1999 held positions of increasing responsibility in R&D, Development and Operations. In 1999, he was promoted to Senior Vice President, Operations for Bayer Biologicals.
Dr. Kamarck graduated from Oberlin College in 1973. He received his Ph.D. in Biochemistry from MIT in 1979. From 1979 to 1982, he was a Fellow of the Leukemia Society of America at Yale University. He is the author of more than 50 peer-reviewed publications and 20 issued patents. He received an Honorary Doctorate of Science from University of Dublin in June 2009.
